Table of Contents

    Topic review

    CHST3-Related Skeletal Dysplasia

    Subjects: Genetics
    View times: 4
    Submitted by: Catherine Yang
    (This entry belongs to Entry Collection "MedlinePlus ")

    Definition

    CHST3-related skeletal dysplasia is a genetic condition characterized by bone and joint abnormalities that worsen over time. Affected individuals have short stature throughout life, with an adult height under 4 and a half feet. Joint dislocations, most often affecting the knees, hips, and elbows, are present at birth (congenital). Other bone and joint abnormalities can include an inward- and upward-turning foot (clubfoot), a limited range of motion in large joints, and abnormal curvature of the spine. The features of CHST3-related skeletal dysplasia are usually limited to the bones and joints; however, minor heart defects have been reported in a few affected individuals.

    1. Introduction

    Researchers have not settled on a preferred name for this condition. It is sometimes known as autosomal recessive Larsen syndrome based on its similarity to another skeletal disorder called Larsen syndrome. Other names that have been used to describe the condition include spondyloepiphyseal dysplasia, Omani type; humero-spinal dysostosis; and chondrodysplasia with multiple dislocations. Recently, researchers have proposed the umbrella term CHST3-related skeletal dysplasia to refer to bone and joint abnormalities resulting from mutations in the CHST3 gene.

    2. Frequency

    The prevalence of CHST3-related skeletal dysplasia is unknown. More than 30 affected individuals have been reported.

    3. Causes

    As its name suggests, CHST3-related skeletal dysplasia results from mutations in the CHST3 gene. This gene provides instructions for making an enzyme called C6ST-1, which is essential for the normal development of cartilage. Cartilage is a tough, flexible tissue that makes up much of the skeleton during early development. Most cartilage is later converted to bone, except for the cartilage that continues to cover and protect the ends of bones and is present in the nose and external ears. Mutations in the CHST3 gene reduce or eliminate the activity of the C6ST-1 enzyme. A shortage of this enzyme disrupts the normal development of cartilage and bone, resulting in the abnormalities associated with CHST3-related skeletal dysplasia.

    4. Inheritance

    This condition is inherited in an autosomal recessive pattern, which means both copies of the gene in each cell have mutations. The parents of an individual with an autosomal recessive condition each carry one copy of the mutated gene, but they typically do not show signs and symptoms of the condition.

    5. Other Names for This Condition

    • autosomal recessive Larsen syndrome
    • CDMD
    • chondrodysplasia with multiple dislocations
    • humero-spinal dysostosis
    • SED with luxations, CHST3 type
    • SED, Omani type
    • spondyloepiphyseal dysplasia with congenital joint dislocations
    • spondyloepiphyseal dysplasia, Omani type

    The entry is from https://medlineplus.gov/genetics/condition/chst3-related-skeletal-dysplasia

    References

    1. Hermanns P, Unger S, Rossi A, Perez-Aytes A, Cortina H, Bonafé L, Boccone L,Setzu V, Dutoit M, Sangiorgi L, Pecora F, Reicherter K, Nishimura G, Spranger J, Zabel B, Superti-Furga A. Congenital joint dislocations caused by carbohydratesulfotransferase 3 deficiency in recessive Larsen syndrome and humero-spinaldysostosis. Am J Hum Genet. 2008 Jun;82(6):1368-74. doi:10.1016/j.ajhg.2008.05.006. Erratum in: Am J Hum Genet. 2008 Aug;83(2):293.
    2. Rajab A, Kunze J, Mundlos S. Spondyloepiphyseal dysplasia Omani type: a newrecessive type of SED with progressive spinal involvement. Am J Med Genet A. 2004May 1;126A(4):413-9.
    3. Superti-Furga A, Unger S. CHST3-Related Skeletal Dysplasia. 2011 Sep 1[updated 2019 Jan 31]. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): Universityof Washington, Seattle; 1993-2020. Available fromhttp://www.ncbi.nlm.nih.gov/books/NBK62112/
    4. Thiele H, Sakano M, Kitagawa H, Sugahara K, Rajab A, Höhne W, Ritter H,Leschik G, Nürnberg P, Mundlos S. Loss of chondroitin 6-O-sulfotransferase-1function results in severe human chondrodysplasia with progressive spinalinvolvement. Proc Natl Acad Sci U S A. 2004 Jul 6;101(27):10155-60.
    5. Tuysuz B, Mizumoto S, Sugahara K, Celebi A, Mundlos S, Turkmen S. Omani-typespondyloepiphyseal dysplasia with cardiac involvement caused by a missensemutation in CHST3. Clin Genet. 2009 Apr;75(4):375-83. doi:10.1111/j.1399-0004.2009.01167.x.
    6. Unger S, Lausch E, Rossi A, Mégarbané A, Sillence D, Alcausin M, Aytes A,Mendoza-Londono R, Nampoothiri S, Afroze B, Hall B, Lo IF, Lam ST, Hoefele J,Rost I, Wakeling E, Mangold E, Godbole K, Vatanavicharn N, Franco LM, Chandler K,Hollander S, Velten T, Reicherter K, Spranger J, Robertson S, Bonafé L, Zabel B, Superti-Furga A. Phenotypic features of carbohydrate sulfotransferase 3 (CHST3)deficiency in 24 patients: congenital dislocations and vertebral changes asprincipal diagnostic features. Am J Med Genet A. 2010 Oct;152A(10):2543-9. doi:10.1002/ajmg.a.33641.
    7. van Roij MH, Mizumoto S, Yamada S, Morgan T, Tan-Sindhunata MB,Meijers-Heijboer H, Verbeke JI, Markie D, Sugahara K, Robertson SP.Spondyloepiphyseal dysplasia, Omani type: further definition of the phenotype. AmJ Med Genet A. 2008 Sep 15;146A(18):2376-84. doi: 10.1002/ajmg.a.32482.
    More